Remove ALS Remove Coronary Remove Plasma
article thumbnail

Profound ST depression in II, III, aVF

Dr. Smith's ECG Blog

I was not worried for a coronary etiology. Peak plasma concentration of amphetamines is rapid ( within minutes ) following inhalation or injection. PEARL #3: The pathophysiologic mechanism for producing amphetamine-induced acute MI is unclear ( Bazmi et al — SQUMJ 17(10); e31-37, 2017 — and — Sinha et al — Case Rep Cardiol, 2016 ).

article thumbnail

STEMI with Life-Threatening Hypokalemia and Incessant Torsades de Pointes

Dr. Smith's ECG Blog

the associated loss is double, at 200-400 mEq.* [ Sterns RH, et al. Internal potassium balance and the control of the plasma potassium concentration. Plasma potassium ([K] p ) was measured at 15-minute intervals during and after the infusion in 31 patients. The estimated deficit associated with a serum decrease from 4.0

STEMI 52
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Electrical instability in a healthy 50 year old. How to manage?

Dr. Smith's ECG Blog

CT coronary angiogram showed a hypoplastic RCA and dominant LCx. The minimum effective plasma concentration of flecainide is about 200 ng/mL. This plasma concentration leads to a QRS prolongation of about 10 msec. At plasma concentration peak ( after 90120 min. ) record another ECG and calculate the QRS duration. =

Plasma 72
article thumbnail

The Basics of Dexmedetomidine

Don't Forget the Bubbles

This is likely because Dexmed helps dampen the sympathetic response to perioperative stress, improving coronary artery perfusion. Later phase : As plasma levels fall, vasoconstriction decreases. References Baserga M, DuPont TL, Ostrander B, et al. 2021.770511 Bayram A, Ulgey A, Baykan A, et al. Front Pain Res (Lausanne).

E-9-1-1 59
article thumbnail

Systemic Lupus Erythematosus: ED presentations, evaluation, and management

EMDocs

SLE is considered an atypical risk factor for cardiovascular disease and acute coronary syndrome(8,9,11). Treatment requiresaggressive anticoagulation, glucocorticoids, plasma exchange, and intravenous immunoglobulin (IVIG)(27). Aringer M, Costenbader K, Daikh D, et al. Meier AL, Bodmer NS, Wirth C, et al.

ED 71